|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meyers PA, Heller G, Healey JH, Huvos A,
Applewhite A, Sun M and LaQuaglia M: Osteogenic sarcoma with
clinically detectable metastasis at initial presentation. J Clin
Oncol. 11:449–453. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kager L, Zoubek A, Pötschger U, Kastner U,
Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M,
Winkelmann W, et al: Primary metastatic osteosarcoma: Presentation
and outcome of patients treated on neoadjuvant Cooperative
Osteosarcoma Study Group protocols. J Clin Oncol. 21:2011–2018.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng Z, Liu C and Wu M: New insights into
long noncoding RNAs and their roles in glioma. Mol Cancer.
17:612018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo Z, Xiao L, Li J, Dong B and Wang C:
Integrative analysis reveals driver long non-coding RNAs in
osteosarcoma. Medicine (Baltimore). 98:e143022019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ren K, Ni Y, Li X, Wang C, Chang Q, Li Y,
Gao Z, Wu S, Shi X, Song J, et al: Expression profiling of long
noncoding RNAs associated with vasculogenic mimicry in
osteosarcoma. J Cell Biochem. 120:12473–12488. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, Egranov SD, Yang L and Lin C:
Molecular mechanisms of long noncoding RNAs-mediated cancer
metastasis. Genes Chromosomes Cancer. 58:200–207. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akhade VS, Pal D and Kanduri C: Long
noncoding RNA: Genome organization and mechanism of action. Adv Exp
Med Biol. 1008:47–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deans C and Maggert KA: What do you mean,
‘epigenetic’? Genetics. 199:887–896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Z, Gao Y, Yao L, Liu Y, Huang L, Yan
Z, Zhao W, Zhu P and Weng H: LncFZD6 initiates Wnt/β-catenin and
liver TIC self-renewal through BRG1-mediated FZD6 transcriptional
activation. Oncogene. 37:3098–3112. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng J, Mueller M, Geng T, Shen Y, Liu Y,
Hou P, Mamillapalli R, Taylor HS, Paidas M and Huang Y: Correction:
H19 LncRNA alters methylation and expression of Hnf4α in the liver
of metformin-exposed fetuses. Cell Death Dis. 10:5922019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jain AK, Xi Y, McCarthy R, Allton K,
Akdemir KC, Patel LR, Aronow B, Lin C, Li W, Yang L and Barton MC:
LncPRESS1 Is a p53-regulated LncRNA that safeguards pluripotency by
disrupting SIRT6-mediated De-acetylation of histone H3K56. Mol
Cell. 64:967–981. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tam C, Wong JH, Tsui SKW, Zuo T, Chan TF
and Ng TB: LncRNAs with miRNAs in regulation of gastric, liver, and
colorectal cancers: Updates in recent years. Appl Microbiol
Biotechnol. 103:4649–4677. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Léveillé N and Baglio SR:
Exosome-transferred LncRNAs at the core of cancer bone lesions.
Crit Rev Oncol Hematol. 139:125–127. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong Z and Wang Y: LncRNA BLACAT1
accelerates the proliferation and migration of osteosarcoma cells
through regulating STAT3. Pathol Res Pract. 215:571–579. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao W and Li L: SP1-induced upregulation
of long non-coding RNA HCP5 promotes the development of
osteosarcoma. Pathol Res Pract. 215:439–445. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen S, Li W and Guo A: LOXL1-AS1 predicts
poor prognosis and promotes cell proliferation, migration, and
invasion in osteosarcoma. Biosci Rep. 39:BSR201904472019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Su X, Teng J, Jin G, Li J, Zhao Z, Cao X,
Guo Y, Guo M, Li X, Wu J, et al: ELK1-induced upregulation of long
non-coding RNA MIR100HG predicts poor prognosis and promotes the
progression of osteosarcoma by epigenetically silencing LATS1 and
LATS2. Biomed Pharmacother. 109:788–797. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang T, Wan CY, Mei XL, Jia P and Wang
MJ: Long Non-coding RNA HULC promotes progression of bone
neoplasms. Med Sci Monit. 24:5754–5760. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li P, Huang R, Huang T, Cheng S, Chen Y
and Wang Z: Long non-coding RNA NEAT1 promotes proliferation,
migration and invasion of human osteosarcoma cells. Int J Med Sci.
15:1227–1234. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu W, Zhang E, Song L, Tu L, Wang Z, Tian
F, Aikenmu K, Chu G and Zhao J: Long noncoding RNA HOXD-AS1
aggravates osteosarcoma carcinogenesis through epigenetically
inhibiting p57 via EZH2. Biomed Pharmacother. 106:890–895. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang L, Ge D, Chen X, Qiu J, Yin Z, Zheng
S and Jiang C: FOXP4-AS1 participates in the development and
progression of osteosarcoma by downregulating LATS1 via binding to
LSD1 and EZH2. Biochem Biophys Res Commun. 502:493–500. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu G, Liu G, Yuan D, Dai J, Cui Y and Tang
X: Long non-coding RNA ANRIL is associated with a poor prognosis of
osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway. J
Bone Oncol. 11:51–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ye H, Lin J, Yao X, Li Y, Lin X and Lu H:
Overexpression of long Non-coding RNA NNT-AS1 correlates with tumor
progression and poor prognosis in osteosarcoma. Cell Physiol
Biochem. 45:1904–1914. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Zhang Y, Mao Y and Ma X: The
LncRNA PCAT1 is correlated with poor prognosis and promotes cell
proliferation, invasion, migration and EMT in osteosarcoma. Onco
Targets Ther. 11:629–638. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Z, Tang Y, Xing W, Dong W and Wang Z:
LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion
and migration by regulating Notch1 signaling and
epithelial-mesenchymal transition. Exp Mol Pathol. 104:19–25. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bayoumi AS, Sayed A, Broskova Z, Teoh JP,
Wilson J, Su H, Tang YL and Kim IM: Crosstalk between long
noncoding RNAs and MicroRNAs in health and disease. Int J Mol Sci.
17:3562016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu
J, Miao N, Shen J and Peng T: LncRNA DANCR promotes tumor
progression and cancer stemness features in osteosarcoma by
upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 405:46–55.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma H, Su R, Feng H, Guo Y and Su G: Long
noncoding RNA UCA1 promotes osteosarcoma metastasis through
CREB1-mediated epithelial-mesenchymal transition and activating
PI3K/AKT/mTOR pathway. J Bone Oncol. 16:1002282019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liao S, Xing S and Ma Y: LncRNA SNHG16
sponges miR-98-5p to regulate cellular processes in osteosarcoma.
Cancer Chemother Pharmacol. 83:1065–1074. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang N, Meng X, Mei L, Zhao C and Chen W:
LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in
osteosarcoma through modulating miR-641/HOXA9 signaling pathway. J
Cell Biochem. Mar 6–2019.doi: 10.1002/jcb.28426 (Epub Ahead of
Print).
|
|
33
|
Sun Z, Zhang T and Chen B: Long Non-coding
RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1)
promotes proliferation and metastasis of osteosarcoma cells by
targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b. Med Sci
Monit. 25:1410–1422. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng R, Zhang J and Chen J: LncRNA SNHG1
negatively regulates miRNA-101-3p to enhance the expression of
ROCK1 and promote cell proliferation, migration and invasion in
osteosarcoma. Int J Mol Med. 43:1157–1166. 2019.PubMed/NCBI
|
|
35
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.PubMed/NCBI
|
|
36
|
Dai J, Xu L, Hu X, Han G, Jiang H, Sun H,
Zhu G and Tang X: Long noncoding RNA OIP5-AS1 accelerates CDK14
expression to promote osteosarcoma tumorigenesis via targeting
miR-223. Biomed Pharmacother. 106:1441–1447. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Y, Zhang T, Zhang Y, Zhao X and Wang W:
Targeting the FOXM1-regulated long noncoding RNA TUG1 in
osteosarcoma. Cancer Sci. 109:3093–3104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li G, Liu K and Du X: Long Non-coding RNA
TUG1 promotes proliferation and inhibits apoptosis of osteosarcoma
cells by sponging miR-132-3p and Upregulating SOX4 expression.
Yonsei Med J. 59:226–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang Y, Zhang R, Cheng G, Xu R and Han X:
Long non-coding RNA HOXA-AS2 promotes migration and invasion by
acting as a ceRNA of miR-520c-3p in osteosarcoma cells. Cell Cycle.
17:1637–1648. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Deng Y, Zhao F, Zhang Z, Sun F and Wang M:
Long noncoding RNA SNHG7 promotes the tumor growth and
epithelial-to-mesenchymal transition via regulation of miR-34a
Signals in osteosarcoma. Cancer Biother Radiopharm. 33:365–372.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gu Z, Hou Z, Zheng L, Wang X, Wu L and
Zhang C: Long noncoding RNA LINC00858 promotes osteosarcoma through
regulating miR-139-CDK14 axis. Biochem Biophys Res Commun.
503:1134–1140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li R, Liu S, Li Y, Tang Q, Xie Y and Zhai
R: Long noncoding RNA AFAP1-AS1 enhances cell proliferation and
invasion in osteosarcoma through regulating
miR-4695-5p/TCF4-β-catenin signaling. Mol Med Rep. 18:1616–1622.
2018.PubMed/NCBI
|
|
43
|
Xia B, Wang L, Feng L, Tian B, Tan Y and
Du B: Knockdown of long noncoding RNA CAT104 inhibits the
proliferation, migration, and invasion of human osteosarcoma cells
by regulating MicroRNA-381. Oncol Res. 27:89–98. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao J, Zhang C, Gao Z, Wu H, Gu R and
Jiang R: Long non-coding RNA ASBEL promotes osteosarcoma cell
proliferation, migration, and invasion by regulating microRNA-21. J
Cell Biochem. 119:6461–6469. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou S, Yu L, Xiong M and Dai G: LncRNA
SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by
upregulating Notch2 by sponging miR-195-5p. Biochem Biophys Res
Commun. 495:1822–1832. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu KP, Ma XL and Zhang CL: LncRNA ODRUL
contributes to osteosarcoma progression through the miR-3182/MMP2
Axis. Mol Ther. 25:2383–2393. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H
and Jia L: LncRNA SNHG20 knockdown suppresses the osteosarcoma
tumorigenesis through the mitochondrial apoptosis pathway by
miR-139/RUNX2 axis. Biochem Biophys Res Commun. 503:1927–1933.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhao D, Wang S, Chu X and Han D: LncRNA
HIF2PUT inhibited osteosarcoma stem cells proliferation, migration
and invasion by regulating HIF2 expression. Artif Cells Nanomed
Biotechnol. 47:1342–1348. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhao W, Zhang D, Qin P, Zhang J, Cui X,
Gao J, Wang J and Li J: Long non-coding RNA EPIC1 inhibits
viability and invasion of osteosarcoma cells by promoting MEF2D
ubiquitylation. Int J Biol Macromol. 128:566–573. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen ZX, Li QC, Liu ZZ, Liang RD and Huang
B: Long non-coding RNA RAB11B-AS1 prevents osteosarcoma
proliferation via its sense gene RAB11B. Zhonghua Yi Xue Za Zhi.
98:2509–2514. 2018.(In Chinese). PubMed/NCBI
|
|
52
|
Qu G, Ma Z, Tong W and Yang J: LncRNA
WWOX-AS1 inhibits the proliferation, migration and invasion of
osteosarcoma cells. Mol Med Rep. 18:779–788. 2018.PubMed/NCBI
|
|
53
|
Zhao J and Ma ST: Downregulation of LncRNA
H19 inhibits migration and invasion of human osteosarcoma through
the NF-κB pathway. Mol Med Rep. 17:7388–7394. 2018.PubMed/NCBI
|
|
54
|
Zhang ZC, Tang C, Dong Y, Zhang J, Yuan T,
Tao SC and Li XL: Targeting the long noncoding RNA MALAT1 blocks
the pro-angiogenic effects of osteosarcoma and suppresses tumour
growth. Int J Biol Sci. 13:1398–1408. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang SZ, Cai L and Li B: MEG3 long
non-coding RNA prevents cell growth and metastasis of osteosarcoma.
Bratisl Lek Listy. 118:632–636. 2017.PubMed/NCBI
|
|
56
|
Sun L, Yang C, Xu J, Feng Y, Wang L and
Cui T: Long noncoding RNA EWSAT1 promotes osteosarcoma cell growth
and metastasis through suppression of MEG3 expression. DNA Cell
Biol. 35:812–818. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Guo W, Jiang H, Li H, Li F, Yu Q, Liu Y,
Jiang W and Zhang M: LncRNA-SRA1 suppresses osteosarcoma cell
proliferation while promoting cell apoptosis. Technol Cancer Res
Treat. 18:15330338198414382019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Fei D, Zhang X, Liu J, Tan L, Xing J, Zhao
D and Zhang Y: Long noncoding RNA FER1L4 suppresses tumorigenesis
by regulating the expression of PTEN targeting miR-18a-5p in
osteosarcoma. Cell Physiol Biochem. 51:1364–1375. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Han W and Liu J: LncRNA-p21 inhibited the
proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT
signaling pathway. Biomed Pharmacother. 97:911–918. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yang C, Wang G, Yang J and Wang L: Long
noncoding RNA NBAT1 negatively modulates growth and metastasis of
osteosarcoma cells through suppression of miR-21. Am J Cancer Res.
7:2009–2019. 2017.PubMed/NCBI
|
|
61
|
Sun ZY, Jian YK, Zhu HY and Li B:
LncRNAPVT1 targets miR-152 to enhance chemoresistance of
osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT
pathway. Pathol Res Pract. 215:555–563. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Qi X, Yu XJ, Wang XM, Song TN, Zhang J,
Guo XZ, Li GJ and Shao M: Knockdown of KCNQ1OT1 suppresses cell
invasion and sensitizes osteosarcoma cells to CDDP by upregulating
DNMT1-mediated Kcnq1 expression. Mol Ther Nucleic Acids.
17:804–818. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhou Q, Hu T and Xu Y: Anticancer
potential of TUG1 knockdown in cisplatin-resistant osteosarcoma
through inhibition of MET/Akt signalling. J Drug Target.
28:204–211. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Song L, Zhou Z, Gan Y, Li P, Xu Y, Zhang
Z, Luo F, Xu J, Zhou Q and Dai F: Long noncoding RNA OIP5-AS1
causes cisplatin resistance in osteosarcoma through inducing the
LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
J Cell Biochem. 120:9656–9666. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Li G and Zhu Y: Effect of LncRNA ANRIL
knockdown on proliferation and cisplatin chemoresistance of
osteosarcoma cells in vitro. Pathol Res Pract. 215:931–938. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhou B, Li L, Li Y, Sun H and Zeng C: Long
noncoding RNA SNHG12 mediates doxorubicin resistance of
osteosarcoma via miR-320a/MCL1 axis. Biomed Pharmacother.
106:850–857. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang CL, Zhu KP and Ma XL: Antisense
LncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by
increasing the expression of FOXC2. Cancer Lett. 396:66–75. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Han Z and Shi L: Long non-coding RNA
LUCAT1 modulates methotrexate resistance in osteosarcoma via
miR-200c/ABCB1 axis. Biochem Biophys Res Commun. 495:947–953. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.PubMed/NCBI
|
|
70
|
Hu T, Fei Z, Su H, Xie R and Chen L:
Polydatin inhibits proliferation and promotes apoptosis of
doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated
suppression of Akt signaling. Toxicol Appl Pharmacol. 371:55–62.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Shi T, Gao G and Cao Y: Long noncoding
RNAs as novel biomarkers have a promising future in cancer
diagnostics. Dis Markers. 2016:90851952016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Begolli R, Sideris N and Giakountis A:
LncRNAs as chromatin regulators in cancer: From molecular function
to clinical potential. Cancers (Basel). 11:15242019. View Article : Google Scholar
|
|
74
|
Miranda-Castro R, de-Los-Santos-Álvarez N
and Lobo-Castañón MJ: Long noncoding RNAs: From genomic junk to
rising stars in the early detection of cancer. Anal Bioanal Chem.
411:4265–4275. 2019. View Article : Google Scholar : PubMed/NCBI
|
